Latest ZEAL reports update at 2023-12-23: 2021 ∙ 2020 ∙ 2019

Zealand Pharma A/S ZEAL

$ 17.47 0.52%

Zealand Pharma A/S Financial Statements 2011-2024 | ZEAL

Annual Financial Statements Zealand Pharma A/S

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	855 M	1.08 B	1.29 B	441 M	465 M	-	-	-	-	-	-
Shares	43.2 M	33.8 M	33.8 M	30.7 M	27.9 M	-	-	-	-	-	-
Historical Prices	19.8	31.9	38.3	14.7	16.9	-	-	-	-	-	-
Net Income	-1.02 B	-847 M	-572 M	581 M	-272 M	-154 M	-114 M	-65 M	-184 M	36.4 M	13.4 M
Revenue	293 M	353 M	41.3 M	38 M	140 M	235 M	188 M	154 M	6.57 M	224 M	142 M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	174 M	263 M	40.9 M	-142 M	125 M	203 M	165 M	140 M	5.7 M	208 M	142 M
Operating Income	-1.05 B	-792 M	-588 M	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-1.05 B	-792 M	-588 M	-653 M	-242 M	-110 M	-75.1 M	-67.6 M	-180 M	37.7 M	12.9 M
Operating Expenses	-	1.09 B	629 M	516 M	372 M	319 M	247 M	214 M	191 M	175 M	133 M
General and Administrative Expenses	-	203 M	67.9 M	78 M	47.5 M	52.5 M	44.6 M	39.8 M	34.2 M	27.6 M	34.9 M

All numbers in DKK currency

Quarterly Income Statement Zealand Pharma A/S

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	39.8 M	-	-	-	33 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-229 M	-	-	-	-113 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	56.5 M	-	-	-	9.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	34.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	22.3 M	-	-	-	9.69 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-218 M	-	-	-	-130 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-218 M	-	-	-	-130 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in DKK currency